GlassScriptPhysician profile
Luis Abraham Mata
NPI 1861785503
$21,045.48
in general payments reported to CMS, 2019-2025
34 companies · $2,511 in 2025
The $2,511 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,010 · 2020: $1,248 · 2021: $1,303 · 2022: $1,169 · 2023: $2,766 · 2024: $3,039 · 2025: $2,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,822 · Travel and Lodging: $2,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,821.98 |
| Travel and Lodging | $2,493.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $4,382.79 | 2019-2024 | (Bh4) Igt Devices Undivided, (Dd3) Venous Stent Und, (Dd1) Duo Hybrid |
| Medtronic Vascular, INC. | $2,677.06 | 2019-2020 | |
| Abbott Laboratories | $2,650.07 | 2019-2025 | Perclose Proglide, Proclaim, Absolute Pro |
| W. L. Gore & Associates, INC. | $1,983.28 | 2019-2024 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Silk Road Medical, INC. | $1,480.74 | 2019-2022 | |
| Angiodynamics, INC. | $1,085.72 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Cardiovascular Systems INC. | $1,063.24 | 2019-2022 | |
| Boston Scientific Corporation | $975.81 | 2021-2025 | Eluvia, Ranger, Jetstream Sc |
| Nalu Medical, INC. | $632.23 | 2024-2025 | Nalu Neurostimulation System |
| Bard Peripheral Vascular, INC. | $588.90 | 2019-2020 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $583.17 | 2019 | |
| Penumbra, INC. | $545.25 | 2021-2024 | Indigo System, Penumbra System |
| Shockwave Medical, INC | $338.10 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Smith+Nephew, INC. | $326.03 | 2020-2021 | |
| Koya Medical, INC. | $220.02 | 2025 | Koya Medical, Dayspring |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $199.86 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Medtronic, INC. | $185.06 | 2022-2024 | Endurant Iis |
| Terumo Medical Corporation | $163.84 | 2019-2020 | |
| Nevro Corp. | $154.93 | 2024 | Senza |
| Cordis US Corp. | $142.21 | 2024 | Mynxgrip, Mynx Venous Vcd |
| Inari Medical, INC. | $139.64 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Averitas Pharma INC. | $124.99 | 2025 | Qutenza |
| Edwards Lifesciences Corporation | $90.16 | 2025 | |
| Globus Medical, INC. | $64.20 | 2025 | Senza |
| Organogenesis INC. | $58.00 | 2021 | |
| Pfizer INC. | $30.77 | 2019-2025 | |
| Allergan, INC. | $27.10 | 2019 | |
| Kci USA, INC. | $27.00 | 2022 | |
| Surmodics, INC. | $24.99 | 2024 | Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy System |
| Janssen Pharmaceuticals, INC | $21.93 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $15.48 | 2024 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $15.31 | 2024 | Eliquis |
| Cashflow Solutions, LLC | $14.08 | 2023 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Cook Medical LLC | $13.52 | 2023 | Zilver Ptx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Mata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.